Home Other Building Blocks 3-Chloropyridazine

3-Chloropyridazine

CAS No.:
1120-95-2
Catalog Number:
AG0033ON
Molecular Formula:
C4H3ClN2
Molecular Weight:
114.5330
Pack Size
Purity
Availability
Location
Price(USD)
Quantity
  
1g
97%
In Stock USA
United States
$163
- +
5g
97%
In Stock USA
United States
$488
- +
10g
97%
In Stock USA
United States
$813
- +
25g
97%
In Stock USA
United States
$1219
- +
Product Description
Catalog Number:
AG0033ON
Chemical Name:
3-Chloropyridazine
CAS Number:
1120-95-2
Molecular Formula:
C4H3ClN2
Molecular Weight:
114.5330
MDL Number:
MFCD06801356
IUPAC Name:
3-chloropyridazine
InChI:
InChI=1S/C4H3ClN2/c5-4-2-1-3-6-7-4/h1-3H
InChI Key:
IBWYHNOFSKJKKY-UHFFFAOYSA-N
SMILES:
Clc1cccnn1
Properties
Complexity:
57.7  
Compound Is Canonicalized:
Yes
Covalently-Bonded Unit Count:
1  
Defined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Exact Mass:
113.998g/mol
Formal Charge:
0
Heavy Atom Count:
7  
Hydrogen Bond Acceptor Count:
2  
Hydrogen Bond Donor Count:
0
Isotope Atom Count:
0
Molecular Weight:
114.532g/mol
Monoisotopic Mass:
113.998g/mol
Rotatable Bond Count:
0
Topological Polar Surface Area:
25.8A^2
Undefined Atom Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
XLogP3:
0.1  
Literature
Title Journal
6-Chloro-N-(2-meth-oxy-phen-yl)pyridazin-3-amine. Acta crystallographica. Section E, Structure reports online 20120201
Pharmacophore-based design, synthesis, and biological evaluation of novel chloro-pyridazine piperazines as human rhinovirus (HRV-3) inhibitors. Bioorganic & medicinal chemistry letters 20110201
3-Chloro-6-(3,5-dimethyl-1H-pyrazol-1-yl)pyridazine. Acta crystallographica. Section E, Structure reports online 20101001
Gram-scale synthesis of the p38α MAPK-inhibitor VX-745 for preclinical studies into Werner syndrome. Future medicinal chemistry 20100901
3-Chloro-6-{4-[3-(trifluoro-meth-yl)phen-yl]piperazin-1-yl}pyridazine. Acta crystallographica. Section E, Structure reports online 20100301
3-Chloro-6-[4-(2-pyrid-yl)piperazin-1-yl]pyridazine. Acta crystallographica. Section E, Structure reports online 20100101
Synthesis and evaluation of novel chloropyridazine derivatives as potent human rhinovirus (HRV) capsid-binding inhibitors. Bioorganic & medicinal chemistry 20090115
Screening and evaluation of antioxidant activity of some pyridazine derivatives. Journal of enzyme inhibition and medicinal chemistry 20080401
Synthesis of a new scaffold: the 7H,8H-pyrimido[1,6-b]pyridazin-6,8-dione nucleus. Molecules (Basel, Switzerland) 20071230
An efficient synthesis and reactions of novel indolylpyridazinone derivatives with expected biological activity. Molecules (Basel, Switzerland) 20070110
Docking of 6-chloropyridazin-3-yl derivatives active on nicotinic acetylcholine receptors into molluscan acetylcholine binding protein (AChBP). Farmaco (Societa chimica italiana : 1989) 20050401
Solid-phase syntheses of 6-arylpyridazin-3(2H)-ones. Journal of combinatorial chemistry 20050101
6-Chloropyridazin-3-yl derivatives active as nicotinic agents: synthesis, binding, and modeling studies. Journal of medicinal chemistry 20020829
Properties